110520 ⎘
ssDNA viruses; Details; Parvoviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
#2METHOD FOR INHIBITING ZOPHOBAS MORIO BLACK WASTING DISEASE
#3Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof
#4Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
#5Methods of vaccine administration
#6VIRUS-LIKE PARTICLE BINDING AGENTS, RELATED COMPOSITIONS, AND RELATED METHODS
#7Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus
#8Coronavirus immunogenic compositions and uses thereof
#9Recombinant porcine parvovirus antigenic protein and use thereof
#10CORONAVIRUS IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#11Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
#12Methods of vaccine administration
#13Paramyxoviridae expression system
#14Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#15Hybrid core feline vaccines
#16Dry formulations of vaccines that are room temperature stable
#17Porcine torque teno virus vaccines and diagnosis
#18Liquid stable virus vaccines
#19Porcine parvovirus 5A, methods of use and vaccine
#20Methods of vaccine administration
#21Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#22Liquid stable virus vaccines
#23Vaccines containing canine parvovirus genetic variants
#24Porcine torque teno virus vaccines and diagnosis
#25Inactivated FCV vaccines
#26METHODS OF VACCINE ADMINISTRATION
#27Inactivated FCV vaccines
#28Vaccines containing canine parvovirus genetic variants
#29Raccoon poxvirus expressing rabies glycoproteins
#30Vaccine For Periodontal Disease
#31Canine combination vaccines
#32Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
#33Probiotic enterococci for improved immunity
#34Inactivated FCV vaccines
#35Vaccine for periodontal disease